Publicaciones en las que colabora con Begoña Ochoa Olascoaga (25)

2020

  1. Molecular and cellular insights into the role of SND1 in lipid metabolism

    Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, Vol. 1865, Núm. 5

2019

  1. Lipidomic data uncover extensive heterogeneity in phosphatidylcholine structural variants in HepG2 cells

    Data in Brief

2018

  1. Insights into SND1 oncogene promoter regulation

    Frontiers in Oncology, Vol. 8, Núm. DEC

2017

  1. SREBP-2-driven transcriptional activation of human SND1 oncogene

    Oncotarget, Vol. 8, Núm. 64, pp. 108181-108194

2015

  1. Profiling of promoter occupancy by the SND1 transcriptional coactivator identifies downstream glycerolipid metabolic genes involved in TNFα response in human hepatoma cells

    Nucleic Acids Research, Vol. 43, Núm. 22, pp. 10673-10688

2014

  1. The promoter of cell growth- and RNA protection-associated SND1 gene is activated by endoplasmic reticulum stress in human hepatoma cells

    BMC Biochemistry, Vol. 15, Núm. 1

2013

  1. NF-κB, Sp1 and NF-Y as transcriptional regulators of human SND1 gene

    Biochimie, Vol. 95, Núm. 4, pp. 735-742

2012

  1. Biphasic adaptative responses in VLDL metabolism and lipoprotein homeostasis during Gram-negative endotoxemia

    Innate Immunity, Vol. 18, Núm. 1, pp. 89-99

2009

  1. Interleukin-6 is associated with liver lipid homeostasis but not with cell death in experimental hepatic steatosis

    Innate Immunity, Vol. 15, Núm. 6, pp. 337-349

2008

  1. Kupffer cell products and interleukin 1β directly promote VLDL secretion and apoB mRNA up-regulation in rodent hepatocytes

    Innate Immunity, Vol. 14, Núm. 4, pp. 255-266

2007

  1. Upregulation of apolipoprotein B secretion, but not lipid, by tumor necrosis factor-α in rat hepatocyte cultures in the absence of extracellular fatty acids

    Annals of the New York Academy of Sciences

2006

  1. The 2-series prostaglandins suppress VLDL secretion in an inflammatory condition-dependent manner in primary rat hepatocytes

    Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, Vol. 1761, Núm. 2, pp. 160-171

2004

  1. Differential modulation of prostaglandin receptor mRNA abundance by prostaglandins in primary cultured rat hepatocytes

    Molecular and Cellular Biochemistry, Vol. 266, Núm. 1-2, pp. 183-189

  2. The fatty acid composition of chylomicron remnants influences their propensity to oxidate

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 14, Núm. 5, pp. 241-247

2003

  1. Dual action of neutral sphingomyelinase on rat hepatocytes: Activation of cholesteryl ester metabolism and biliary cholesterol secretion and inhibition of VLDL secretion

    Lipids, Vol. 38, Núm. 1, pp. 53-63

  2. Influence of the fatty acid composition of lipids in chylomicron remnants derived from fish or corn oil on the lipid profile of cultured rat hepatocytes

    Journal of Physiology and Biochemistry, Vol. 59, Núm. 2, pp. 85-100

2001

  1. The influence of chylomicron remnants on cholesteryl ester metabolism in cultured rat hepatocytes: Comparison of the effects of particles enriched in n-3 or n-6 polyunsaturated fatty acids

    Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, Vol. 1534, Núm. 2-3, pp. 96-109

2000

  1. Alterations in erythrocyte membrane lipid and fatty acid composition in Chediak-Higashi syndrome

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1502, Núm. 3, pp. 380-390

1996

  1. Application of 2-hydroxypropyl-β-cyclodextrin in the assay of acyl-CoA:Cholesterol acyltransferase and neutral and acid cholesterol ester hydrolases

    Lipids, Vol. 31, Núm. 3, pp. 323-329

  2. Regulation of bile acid synthesis by estradiol and progesterone in primary cultures of rat hepatocytes

    Experimental and Clinical Endocrinology and Diabetes, Vol. 104, Núm. 2, pp. 137-144